PT-141 Reconstitution and Dose Planner

Published 2026-08-04 · Lyophile Editorial

PT-141 (bremelanotide) ships as lyophilized powder in a 10 mg vial. Your first job: turn that powder into a measurable liquid. The math is simple, but your choice of diluent volume determines whether your syringe reads in single-digit units or fractions of a unit.

This page is a working calculator. Plug in your numbers, check the table, verify against the step-by-step math below.

Concentration Calculator: 10 mg PT-141 Vial

| Diluent added to a 10 mg vial | Concentration | mcg per mL | mcg per unit (U-100) | | --- | --- | --- | --- | | 1.0 mL | 10 mg/mL | 10,000 mcg/mL | 100 mcg | | 2.0 mL | 5 mg/mL | 5,000 mcg/mL | 50 mcg | | 2.5 mL | 4 mg/mL | 4,000 mcg/mL | 40 mcg | | 5.0 mL | 2 mg/mL | 2,000 mcg/mL | 20 mcg |

On a U-100 insulin syringe, 100 units equals 1.0 mL, so one unit is 0.01 mL. Multiply the concentration in mg/mL by 0.01 to get the mass carried by a single unit.

How much bacteriostatic water do I add to a 10 mg PT-141 vial?

Add 2 mL of bacteriostatic water to a 10 mg PT-141 vial for a 5 mg/mL concentration. That gives you 5000 mcg/mL — each 0.01 mL unit on a U-100 insulin syringe carries 50 mcg. At 1 mg dose: 20 units. At 2 mg: 40 units. At 5 mg: the full 100 units.

The 2 mL choice is the sweet spot for subcutaneous injection. It dissolves powder quickly, keeps injection volumes small, and leaves room for the overfill most vials carry. A 10 mg vial typically contains 10.2–10.5 mg of peptide, so your actual concentration runs slightly higher than label math — plan for that on your first draw.

Full concentration table for a 10 mg vial:

| Bac water added | Concentration | mcg per U-100 unit | mcg per 0.1 mL | |---|---|---|---| | 1 mL | 10 mg/mL | 100 mcg | 1000 mcg | | 2 mL | 5 mg/mL | 50 mcg | 500 mcg | | 3 mL | 3.33 mg/mL | 33.3 mcg | 333 mcg | | 4 mL | 2.5 mg/mL | 25 mcg | 250 mcg | | 5 mL | 2 mg/mL | 20 mcg | 200 mcg |

The formula, step by step:

1. Peptide mass in mg ÷ diluent volume in mL = mg/mL
2. mg/mL × 1000 = mcg/mL
3. mcg/mL ÷ 100 = mcg per insulin syringe unit

Example: 10 mg ÷ 2 mL = 5 mg/mL → 5000 mcg/mL → 50 mcg per unit.

Intranasal vs. Subcutaneous Volume Comparison

Subcutaneous dosing at 1–2 mg requires 0.2–0.4 mL from a 5 mg/mL vial. Intranasal delivery needs roughly 10× the volume because nasal mucosa absorption runs at 10–20% of injection bioavailability. A 1 mg subcutaneous-equivalent intranasal dose lands around 5–10 mg of peptide — that's 1–2 mL of liquid, impractical for a single nostril pass.

The volume problem is why intranasal PT-141 research is messy. A standard nasal sprayer delivers 0.1 mL per actuation. To get 5 mg intranasally from a 10 mg/mL solution, you need 5 actuations per nostril. A lot of that liquid runs down the back of the throat or out the front of the nose before absorption.

| Route | Typical dose | Volume at 5 mg/mL | Volume at 10 mg/mL | Practical? | |---|---|---|---|---| | Subcutaneous | 1–2 mg | 0.2–0.4 mL | 0.1–0.2 mL | Yes — single syringe | | Intranasal | 5–10 mg | 1–2 mL | 0.5–1.0 mL | Marginal — multiple sprays | | Intranasal (concentrated) | 5–10 mg | — | 0.5–1.0 mL | Requires 10 mg/mL or higher |

If you're set on intranasal, reconstitute with 1 mL of bac water to hit 10 mg/mL. That gives you 100 mcg per microliter, or 1 mg per 0.1 mL spray. Even then, a 5 mg dose means 5 sprays. The alternative: accept lower delivered dose per spray and adjust research parameters accordingly.

Subcutaneous is the cleaner route for dose control. A 1 mg dose from a 5 mg/mL vial is exactly 0.2 mL — 20 units on a U-100 syringe.

Dose-to-Units Converter: 10 mg Vial with 2 mL Diluent

| Target amount | Volume at 5 mg/mL | Units on a U-100 syringe | | --- | --- | --- | | 0.5 mg | 0.10 mL | 10 units | | 1.0 mg | 0.20 mL | 20 units | | 1.5 mg | 0.30 mL | 30 units | | 2.0 mg | 0.40 mL | 40 units | | 3.0 mg | 0.60 mL | 60 units | | 5.0 mg | 1.00 mL | 100 units |

The arithmetic is: volume (mL) = amount (mg) divided by concentration (mg/mL); units = volume divided by 0.01.

How many units on an insulin syringe is 1 mg of PT-141?

At 5 mg/mL concentration, 1 mg of PT-141 is 20 units on a U-100 insulin syringe. Each unit equals 0.01 mL, and at 5 mg/mL each unit carries 50 mcg of peptide. Two units = 100 mcg. Ten units = 500 mcg. Full 100-unit syringe = 5 mg.

Dose-to-units table for a 10 mg vial reconstituted with 2 mL:

| Target dose | Volume | U-100 syringe units | Visual check | |---|---|---|---| | 0.5 mg | 0.1 mL | 10 units | First line past the needle hub | | 1 mg | 0.2 mL | 20 units | One-fifth of a 1 mL syringe | | 1.5 mg | 0.3 mL | 30 units | Just past the 0.3 mL mark | | 2 mg | 0.4 mL | 40 units | Two-fifths of a 1 mL syringe | | 2.5 mg | 0.5 mL | 50 units | Half syringe | | 5 mg | 1.0 mL | 100 units | Full syringe |

The math: 1 mg ÷ 5 mg/mL = 0.2 mL. Then 0.2 mL ÷ 0.01 mL/unit = 20 units. That's the entire calculation.

Bacteriostatic Water Requirements for a 10 mg Vial

A 10 mg PT-141 vial needs a minimum of 0.5 mL of bacteriostatic water to fully dissolve, but 1–2 mL is the practical range. The 0.5 mL minimum produces a 20 mg/mL solution that's technically injectable but leaves almost no margin for draw error. The 2 mL standard gives you a 5 mg/mL working concentration with comfortable syringe volumes.

Bacteriostatic water is 0.9% benzyl alcohol in USP-grade water for injection. The benzyl alcohol concentration is the key spec — it keeps the solution usable for 28 days after first puncture per USP <797> compounding standards. That 28-day window applies once you've inserted a needle, not from the date of manufacture.

| Diluent volume | Concentration | Doses per vial (at 1 mg) | Doses per vial (at 2 mg) | Vial life after first puncture | |---|---|---|---|---| | 1 mL | 10 mg/mL | 10 | 5 | 28 days (USP <797>) | | 2 mL | 5 mg/mL | 10 | 5 | 28 days (USP <797>) | | 3 mL | 3.33 mg/mL | 10 | 5 | 28 days (USP <797>) |

Note: doses per vial don't change with dilution — you're dividing the same 10 mg of peptide into the same dose sizes. What changes is volume per injection and syringe precision. Smaller volumes = larger concentration = smaller injection volumes but less room for error.

Step-by-Step Reconstitution Protocol

The procedure is the same regardless of your target concentration. Work clean, work slow, verify your math twice before you draw.

1. Wipe the vial stopper with an alcohol swab. Let it dry for 30 seconds — alcohol residue can degrade peptide on contact.
2. Draw your bac water into a 3 mL syringe. Use a separate syringe from the one you'll inject with — reconstitution needles (typically 25G or larger) are bigger than injection needles (29G–31G).
3. Inject the bac water slowly down the inside wall of the vial. Don't blast the powder directly — it can denature the peptide at the impact point. Aim the stream so it runs down the glass.
4. Roll the vial gently between your palms for 30–60 seconds. Do not shake. Shaking creates foam and can cause peptide aggregation.
5. Let it sit for 5–10 minutes. The powder should go into solution without visible particles. If you see clumps, roll more — don't add more water unless you plan to change your target concentration.
6. Draw your dose using a U-100 insulin syringe. Pull the plunger to your target unit mark, then check for air bubbles. Tap the syringe barrel to float bubbles to the hub, then push them out — back into the vial, not the room, to avoid wasting peptide.

Common failure mode: drawing your dose before the powder is fully dissolved. Powder at the bottom of the vial is more concentrated than the liquid above it, so your first draw can be stronger than intended. Always roll and wait until the solution is visually clear.

Where to Source Materials

Bacteriostatic water:

• Bacteriostatic Water Depot — USP-grade, 0.9% benzyl alcohol, 30 mL multi-dose vials
• MedSupply Partners — sterile filtration, lot-tracked, 10 mL and 30 mL formats
• Peptide Warehouse — pre-sterilized, single-use and multi-dose options

Research peptides:

• Alpha Amino USA — per-lot HPLC/MS COA, US-shipped
• PurePeptides — third-party tested, lyophilized in sealed vials
• ResearchChem Supply — batch-specific documentation, cold-chain shipping

For research use only — not clinical guidance. PT-141 is not approved for research use outside of controlled studies. The calculations above assume accurate peptide mass in the vial and precise syringe handling — verify both before every draw.